Represented A SPAC III Acquisition Corp. in connection with its Merger Agreement with Bioserica International Limited

Represented A SPAC III Acquisition Corp., a publicly traded special purpose acquisition company, in connection with its execution of a Merger Agreement with Bioserica International Limited.

Bioserica, a leading supplier of antimicrobial fiber and textile products, was valued at approximately $218 million in this business combination transaction.